Loading
Garofalo Health Care Stock: price and insider trades · Italy
No insider purchase over the last 90 days. The latest was filed 20 Mar 2026.
Garofalo Health Care: what insiders have been doing
Garofalo Health Care belongs to the Health Care sector. Filings by its managers are published through Consob. 9 insiders have disclosed 9 filings since 18 October 2025.
Purchases and sales both appear in the filings: 4 purchases (4 insiders, €38k) and 1 sale (1 insider, €3,480). Purchases outweigh sales by €35k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The filings include the largest purchase, €36k, on 20 March 2026, which represents 0.0076% of the company's market value. The buyers include 4 board members.
For context, the typical company on the same exchange (median of 224 companies) published 3 filings over the same period, against 9 filings here. Since 2023, the database holds 6 purchases and 13 sales by insiders of the company.
The most recent open-market purchase was published on 20 March 2026, 211 days ago. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19).
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from Consob. Past trades are no guide to future returns.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€106,475
6 ops. · all time
Sell Volume
€34M
13 ops. · all time
Who traded when
BuySaleUnknown4 buys
Anonymous (PDMR)1 sale
Since the insiders bought
- Unknown+13.8%Entry €4.55 · Close 15 Oct 2026 €5.18
- +22.7%Entry €4.45 · Close at T+365 €5.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,780 of 24,148 companies
58.3
score / 100
Value61
Quality56
FCF yld3.3%
Earn yld5.0%
EV/EBITDA9.5x
ROE5.5%
Gross mgn85%
Net mgn4.8%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€5.30
Analyst consensus
1 analysts1.00/5
€6.40Target €6.40(+21%)€6.40
Income statement
Revenue€485.1M
Gross profit€410.2M85% margin
EBITDA€72.7M15% margin
Net income€23.4M3.9% margin
Valuation
PER (trailing)25.2x
PER (forward)18.3x
P/Book1.4x
Beta0.37
Balance sheet & cash
Market cap€468.7M
Total debt€225.4M
Free Cash Flow€15.5M
Debt / Equity68%
Profitability & ownership
ROE5.5%
ROA3.8%
% insiders68.3%
% institutions10.5%
Last declaration on 27 July 2026
Declarations36 total
635 shares@ €5.480.0007% mcap100.0% of flowShareXMILISIN IT0005345233CONSOB:187276
4,064 shares0ShareISIN IT0005345233CONSOB:185565
96,537 shares0ShareISIN IT0005345233CONSOB:185564
8,000 shares@ €4.44470.0076% mcap0.1% of flowShareXMILISIN IT0005345233CONSOB:179407
Canonical exit: 16 Jun 2026 (T+90)
110 shares@ €4.520.0001% mcap0.0% of flowShareXMILISIN IT0005345233CONSOB:179404
Canonical exit: 18 Jun 2026 (T+90)
250 shares@ €4.590.0002% mcap0.0% of flowShareXMILISIN IT0005345233CONSOB:179403
Canonical exit: 18 Jun 2026 (T+90)
200 shares@ €4.4450.0002% mcap0.0% of flowShareXMILISIN IT0005345233CONSOB:179276
Canonical exit: 16 Jun 2026 (T+90)
2,668 shares0ShareOTCISIN IT0005345233CONSOB:168267
86,464 shares0ShareOTCISIN IT0005345233CONSOB:168266
1,495 shares0ShareOTCISIN IT0005345233CONSOB:168263
3,203 shares0ShareOTCISIN IT0005345233CONSOB:168262
528 shares@ €5.020.0006% mcap3.6% of flowShareXMILISIN IT0005345233CONSOB:153101
66,490 shares0ShareOTCISIN IT0005345233CONSOB:150090
1,642 shares0ShareOTCISIN IT0005345233CONSOB:150089
1,149 shares0ShareOTCISIN IT0005345233CONSOB:150088
3,732,260 shares@ €4.403.51% mcap48.6% of flowShareXMILISIN IT0005345233CONSOB:141576
5,000 shares@ €4.67610.0050% mcap31.8% of flowShareXMILISIN IT0005345233CONSOB:140992
Canonical exit: 26 Mar 2024 (T+90)
10,000 shares@ €4.50030.0096% mcap61.2% of flowShareXMILISIN IT0005345233CONSOB:140757
Canonical exit: 20 Mar 2024 (T+90)
258 shares@ €4.500.0002% mcap0.0% of flowShareISIN IT0005345233CONSOB:140589
41 shares@ €4.500.0000% mcap0.0% of flowShareISIN IT0005345233CONSOB:140524
265 shares@ €4.500.0003% mcap0.0% of flowShareISIN IT0005345233CONSOB:140455
25 of 36 declarations
About Garofalo Health Care
Garofalo Health Care is an Italian company specializing in the healthcare and pharmaceutical services sector. It is listed on the XMIL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
